Search Results 361-370 of 675 for ★생활안전용품 한인동포 스피드키노분석 ★

  1. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

    A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL).

  2. Lonnie Fynskov, R.N. - Mayo Clinic

    Lonnie Fynskov, R.N., obtained a bachelor of arts degree in nursing and religion from Augustana College in Sioux Falls, S.D., and her certification as a ...

  3. Publications - Leslie T. Cooper, Jr., M.D. - Mayo Clinic

    Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat Commun. 2022 Jan 10; 13 (1):25

  4. Publications - Harold B. Kitaoka, M.D. - Mayo Clinic

    Subtalar arthrodesis versus flexor digitorum longus tendon transfer for severe flatfoot deformity: an in vitro biomechanical analysis. Foot Ankle Int. 1997 Nov; ...

  5. Air Travel Archives - Mayo Clinic News Network

  6. Publications - Brendan C. Lanpher, M.D. - Mayo Clinic

    Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans. J Exp Med. 2024 Aug 5; 221 (8) Epub ...

  7. Publications - Nancy L. Wengenack, Ph.D. - Mayo Clinic

    Rhodococcus infection: a 10-year retrospective analysis of clinical experience and antimicrobial susceptibility profile. J Clin Microbiol. 2024 Mar 13; 62 ...

  8. Mark W. Pataky, Ph.D., M.S. - Mayo Clinic Faculty Profiles

    D., M.S., explores how exercise improves metabolic health. Dr. Pataky uses human skeletal muscle biopsies, rodent models, cell culture models and molecular ...

  9. Sagar Dugani, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Learn more about the research interests of Chandrasagar (Sagar) Dugani, M.D., Ph.D.

  10. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...